Ceritinib

Ceritinib is a prescription medication that belongs to a class of drugs called tyrosine kinase inhibitors. It is used to treat patients with advanced non-small cell lung cancer (NSCLC), a type of lung cancer that has spread or cannot be removed by surgery. The cancer must also be positive for a specific abnormal protein called ALK, which drives the growth and spread of the disease.
Ceritinib works by inhibiting the activity of the ALK protein, thus blocking the signals that tell cancer cells to grow and divide. By blocking this protein, ceritinib can slow down the growth and spread of ALK-positive NSCLC, providing a potential benefit to eligible patients.
It is essential for patients to discuss the benefits and risks of Ceritinib with their healthcare professional before starting treatment. They should also inform their healthcare provider about any other medications they are currently taking, as well as any other medical conditions they may have, to avoid potential drug interactions or complications.